Debt-to-equity of Vaxcyte, Inc. from 31 Mar 2021 to 31 Dec 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
Vaxcyte, Inc. quarterly Debt-to-equity in % history and change rate from 31 Mar 2021 to 31 Dec 2025.
  • Vaxcyte, Inc. Debt-to-equity for the quarter ending 31 Dec 2025 was 8.5%, a 64% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

Vaxcyte, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q4 2025 8.5% +3.3% +64% 31 Dec 2025
Q3 2025 7.2% +1.2% +20% 30 Sep 2025
Q2 2025 5.8% -1.2% -18% 30 Jun 2025
Q1 2025 5.3% -2% -27% 31 Mar 2025
Q4 2024 5.2% -2.6% -34% 31 Dec 2024
Q3 2024 6% +0.12% +2% 30 Sep 2024
Q2 2024 7.1% +0.64% +10% 30 Jun 2024
Q1 2024 7.2% -0.93% -11% 31 Mar 2024
Q4 2023 7.8% -1.7% -17% 31 Dec 2023
Q3 2023 5.9% -7.4% -56% 30 Sep 2023
Q2 2023 6.4% -7% -52% 30 Jun 2023
Q1 2023 8.2% -5.5% -40% 31 Mar 2023
Q4 2022 9.5% -5.5% -37% 31 Dec 2022
Q3 2022 13% -1.5% -10% 30 Sep 2022
Q2 2022 13% -0.1% -0.74% 30 Jun 2022
Q1 2022 14% +1.3% +10% 31 Mar 2022
Q4 2021 15% 31 Dec 2021
Q3 2021 15% 30 Sep 2021
Q2 2021 14% 30 Jun 2021
Q1 2021 12% 31 Mar 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.